Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R de Las Peñas

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 3, 2000
Randomised double blind crossover study comparing ondansetron, granisetron and tropisetron. A cost-benefit analysisE Barrajon, R de las Peñas
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 12, 2014
SEOM guidelines on hydroelectrolytic disordersR De las Peñas, Y Escobar, F Henao, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 12, 2017
SEOM clinical guideline for treatment of cancer pain (2017)C Jara, S Del Barco, C Grávalos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 9, 2019
SEOM clinical guidelines on nutrition in cancer patients (2018)R de Las Peñas, M Majem, J Perez-Altozano, et al.
Sarcoma|January 26, 2007
Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS)A López-Pousa, J Martín, J Montalar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 30, 2016
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)R de Las Peñas, A Blasco, J De Castro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 11, 2019
SEOM clinical guidelines on cardiovascular toxicity (2018)J A Virizuela, A M García, R de Las Peñas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 12, 2017
Peculiarities of the obese patient with cancer: a national consensus statement by the Spanish Society for the Study of Obesity and the Spanish Society of Medical OncologyP Pérez-Segura, J E Palacio, L Vázquez, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancerM Provencio, C Camps, M Cobo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 4, 2015
Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical OncologyA Goday, I Barneto, J M García-Almeida, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 3, 2000
Randomised double blind crossover study comparing ondansetron, granisetron and tropisetron. A cost-benefit analysisE Barrajon, R de las Peñas
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 12, 2014
SEOM guidelines on hydroelectrolytic disordersR De las Peñas, Y Escobar, F Henao, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 12, 2017
SEOM clinical guideline for treatment of cancer pain (2017)C Jara, S Del Barco, C Grávalos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 9, 2019
SEOM clinical guidelines on nutrition in cancer patients (2018)R de Las Peñas, M Majem, J Perez-Altozano, et al.
Sarcoma|January 26, 2007
Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS)A López-Pousa, J Martín, J Montalar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 30, 2016
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)R de Las Peñas, A Blasco, J De Castro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 11, 2019
SEOM clinical guidelines on cardiovascular toxicity (2018)J A Virizuela, A M García, R de Las Peñas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 12, 2017
Peculiarities of the obese patient with cancer: a national consensus statement by the Spanish Society for the Study of Obesity and the Spanish Society of Medical OncologyP Pérez-Segura, J E Palacio, L Vázquez, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancerM Provencio, C Camps, M Cobo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 4, 2015
Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical OncologyA Goday, I Barneto, J M García-Almeida, et al.
Pageof 2